|Public on Jan 22, 2019
|Characterization of microRNA-493-5p targets in liver cell lines (2nd set of data)
|Expression profiling by array
|Primary hepatic tumors mainly include hepatocellular carcinoma (HCC), which is one of the most frequent causes of cancer-related deaths worldwide. Thus far, HCC prognosis has remained extremely poor given the lack of effective treatments. Numerous studies have described the roles played by microRNAs (miRNAs) in cancer progression and the potential of these small noncoding RNAs for diagnostic or therapeutic applications. The current consensus supports the idea that direct repression of a wide range of oncogenes by a single key miRNA may critically affect the malignant properties of cancer cells in a synergistic manner. In this study, we aimed to investigate the oncogenes controlled by miR-493-5p, a major tumor suppressor miRNA that inactivates miR-483-3p oncomir in hepatic cancer cells. Using global gene expression analysis, we highlighted a set of candidate genes potentially regulated by miR-493-5p. In particular, the canonical MYCN proto-oncogene (MYCN) appeared to be an attractive target of miR-493-5p given its significant inhibition via 3’-UTR targeting in miR-493-5p-rescued HCC cells. We showed that MYCN was overexpressed in liver cancer cell lines and clinical samples from HCC patients. Notably, MYCN expression levels were inversely correlated with miR-493-5p in tumor tissues. We confirmed that MYCN knockdown mimicked the anti-cancer effect of miR-493-5p by inhibiting HCC cell growth and invasion, whereas MYCN rescue hindered miR-493-5p activity. In summary, miR-493-5p is a pivotal miRNA that modulates various oncogenes after its re-expression in liver cancer cells, suggesting that tumor suppressor miRNAs with a large spectrum of action may provide valuable tools for miRNA replacement therapies.
|To identify miR-493-5p targets, Hep3B and HepG2 cells were transfected using miR-493-5p mimics and negative control miRNA mimics.
|Gailhouste L, Ochiya T
|Jan 21, 2019
|Last update date
|Jan 01, 2020
|Cluster for Pioneering Research
|Liver Cancer Prevention Research Unit
|408 Main Research Building, 2-1 Hirosawa
|Agilent-039494 SurePrint G3 Human GE v2 8x60K Microarray 039381 (Probe Name version)